help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barbieri, R. L.
Right arrow Articles by Ryan, K. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barbieri, R. L.
Right arrow Articles by Ryan, K. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH

Journal of Clinical Endocrinology & Metabolism, Vol 62, 904-910, Copyright © 1986 by Endocrine Society

ARTICLES

Insulin stimulates androgen accumulation in incubations of ovarian stroma obtained from women with hyperandrogenism

RL Barbieri, A Makris, RW Randall, G Daniels, RW Kistner and KJ Ryan

The effects of insulin and insulin-like growth factors (IGFs) on ovarian androgen production were examined in ovarian stroma obtained from four women with hyperandrogenism and three women without hyperandrogenism. In incubations of stroma obtained from all four hyperandrogenic patients, insulin alone (500 ng/ml) significantly stimulated androstenedione and testosterone release. LH alone (25 ng/ml) significantly stimulated androstenedione release in incubations of stroma obtained from three of the four hyperandrogenic patients and testosterone release in incubations of stroma obtained from one of the four hyperandrogenic patients. In stromal incubations from three of the four hyperandrogenic patients, insulin alone (500 ng/ml) resulted in a significantly greater release of androstenedione and testosterone than did LH alone (25 ng/ml). Dihydrotestosterone was released in measurable quantities in incubations of stromal tissue obtained from three of the four hyperandrogenic women. In all three instances in which dihydrotestosterone was detectable, insulin alone (500 ng/ml), but not LH alone (25 ng/ml), significantly stimulated dihydrostestosterone release. Incubations of stroma obtained from three nonhyperandrogenic, normally cycling women demonstrated low levels of androstenedione release and negligible testosterone and dihydrotestosterone release. Insulin alone (500 ng/ml) and LH alone (25 ng/ml) produced no significant increase in androstenedione release. Insulin (500 ng/ml) plus LH (25 ng/ml) significantly stimulated androstenedione accumulation in stroma obtained from two of the nonhyperandrogenic women. One insulin dose-response experiment was performed using stromal tissue obtained from a hyperandrogenic woman. In this experiment, insulin, at a dose of 50 ng/ml, was as effective as insulin at a dose of 500 ng/ml in stimulating androstenedione and testosterone release. In addition to insulin, IGF-I/somatomedin C (50 ng/ml) stimulated androstenedione and testosterone release. Relaxin (1 microgram/ml) and multiplication-stimulating activity (50 ng/ml) did not stimulate androstenedione and testosterone release. These studies suggest that human ovarian stroma may be a target tissue for insulin and IGF-I, and that hyperinsulinemia may be an important factor contributing to ovarian hyperandrogenism.


This article has been cited by other articles:


Home page
 J. Clin. Endocrinol. Metab.Home page
J. B. Spencer, M. Klein, A. Kumar, and R. Azziz
The Age-Associated Decline of Androgens in Reproductive Age and Menopausal Black and White Women
J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4730 - 4733.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Pasquali, L. Patton, P. Pocognoli, G. E. Cognigni, and A. Gambineri
17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., November 1, 2007; 92(11): 4208 - 4217.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Tian, H. Shen, Q. Lu, R. J. Norman, and J. Wang
Insulin Resistance Increases the Risk of Spontaneous Abortion after Assisted Reproduction Technology Treatment
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1430 - 1433.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
J. B. Flowers, A. T. Oler, S. T. Nadler, Y. Choi, K. L. Schueler, B. S. Yandell, C. M. Kendziorski, and A. D. Attie
Abdominal obesity in BTBR male mice is associated with peripheral but not hepatic insulin resistance
Am J Physiol Endocrinol Metab, March 1, 2007; 292(3): E936 - E945.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. R. McCartney, S. K. Blank, K. A. Prendergast, S. Chhabra, C. A. Eagleson, K. D. Helm, R. Yoo, R. J. Chang, C. M. Foster, S. Caprio, et al.
Obesity and Sex Steroid Changes across Puberty: Evidence for Marked Hyperandrogenemia in Pre- and Early Pubertal Obese Girls
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 430 - 436.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
L. Tosca, P. Solnais, P. Ferre, F. Foufelle, and J. Dupont
Metformin-Induced Stimulation of Adenosine 5' Monophosphate-Activated Protein Kinase (PRKA) Impairs Progesterone Secretion in Rat Granulosa Cells
Biol Reprod, September 1, 2006; 75(3): 342 - 351.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Clin. Nutr.Home page
L. J Moran, M. Noakes, P. M Clifton, G. A Wittert, G. Williams, and R. J Norman
Short-term meal replacements followed by dietary macronutrient restriction enhance weight loss in polycystic ovary syndrome
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 77 - 87.
[Abstract] [Full Text] [PDF]

Home page
 Hum Reprod UpdateHome page
S.K. Blank, C.R. McCartney, and J.C. Marshall
The origins and sequelae of abnormal neuroendocrine function in polycystic ovary syndrome
Hum. Reprod. Update, July 1, 2006; 12(4): 351 - 361.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
M. F. Costello, M. Chapman, and U. Conway
A systematic review and meta-analysis of randomized controlled trials on metformin co-administration during gonadotrophin ovulation induction or IVF in women with polycystic ovary syndrome
Hum. Reprod., June 1, 2006; 21(6): 1387 - 1399.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. R. McCartney, K. A. Prendergast, S. Chhabra, C. A. Eagleson, R. Yoo, R. J. Chang, C. M. Foster, and J. C. Marshall
The Association of Obesity and Hyperandrogenemia during the Pubertal Transition in Girls: Obesity as a Potential Factor in the Genesis of Postpubertal Hyperandrogenism
J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1714 - 1722.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Y. L. Pagan, S. S. Srouji, Y. Jimenez, A. Emerson, S. Gill, and J. E. Hall
Inverse Relationship between Luteinizing Hormone and Body Mass Index in Polycystic Ovarian Syndrome: Investigation of Hypothalamic and Pituitary Contributions
J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1309 - 1316.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. C. Marshall
Obesity in Adolescent Girls: Is Excess Androgen the Real Bad Actor?
J. Clin. Endocrinol. Metab., February 1, 2006; 91(2): 393 - 395.
[Full Text] [PDF]

Home page
 Diabetes CareHome page
M. E. Zanolin, F. Tosi, G. Zoppini, R. Castello, G. Spiazzi, R. Dorizzi, M. Muggeo, and P. Moghetti
Clustering of Cardiovascular Risk Factors Associated With the Insulin Resistance Syndrome: Assessment by principal component analysis in young hyperandrogenic women
Diabetes Care, February 1, 2006; 29(2): 372 - 378.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. Reinehr, G. de Sousa, C. L. Roth, and W. Andler
Androgens before and after Weight Loss in Obese Children
J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5588 - 5595.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
A. Dokras, M. Bochner, E. Hollinrake, S. Markham, B. VanVoorhis, and D. H. Jagasia
Screening Women With Polycystic Ovary Syndrome for Metabolic Syndrome
Obstet. Gynecol., July 1, 2005; 106(1): 131 - 137.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
E. Codner, D. Mook-Kanamori, R. A. Bazaes, N. Unanue, H. Sovino, F. Ugarte, A. Avila, G. Iniguez, and F. Cassorla
Ovarian Function during Puberty in Girls with Type 1 Diabetes Mellitus: Response to Leuprolide
J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 3939 - 3945.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
V. L. Nelson-Degrave, J. K. Wickenheisser, K. L. Hendricks, T. Asano, M. Fujishiro, R. S. Legro, S. R. Kimball, J. F. Strauss III, and J. M. McAllister
Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome
Mol. Endocrinol., February 1, 2005; 19(2): 379 - 390.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Jayagopal, E. S. Kilpatrick, S. Holding, P. E. Jennings, and S. L. Atkin
Orlistat Is as Beneficial as Metformin in the Treatment of Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 729 - 733.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Sepilian and M. Nagamani
Effects of Rosiglitazone in Obese Women with Polycystic Ovary Syndrome and Severe Insulin Resistance
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 60 - 65.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. O. Goodarzi, S. Erickson, S. C. Port, R. I. Jennrich, and S. G. Korenman
{beta}-Cell Function: A Key Pathological Determinant in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., January 1, 2005; 90(1): 310 - 315.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. A. Ganie, M. L. Khurana, M. Eunice, M. Gulati, S. N. Dwivedi, and A. C. Ammini
Comparison of Efficacy of Spironolactone with Metformin in the Management of Polycystic Ovary Syndrome: An Open-Labeled Study
J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2756 - 2762.
[Abstract] [Full Text] [PDF]

Home page
 Ann. N. Y. Acad. Sci.Home page
J. F. STRAUSS III
Some New Thoughts on the Pathophysiology and Genetics of Polycystic Ovary Syndrome
Ann. N.Y. Acad. Sci., November 1, 2003; 997(1): 42 - 48.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. S. Legro, R. Azziz, D. Ehrmann, A. G. Fereshetian, M. O'Keefe, and M. N. Ghazzi
Minimal Response of Circulating Lipids in Women with Polycystic Ovary Syndrome to Improvement in Insulin Sensitivity with Troglitazone
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5137 - 5144.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. A. Eagleson, A. B. Bellows, K. Hu, M. B. Gingrich, and J. C. Marshall
Obese Patients with Polycystic Ovary Syndrome: Evidence that Metformin Does Not Restore Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Ovarian Steroids
J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5158 - 5162.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Silfen, M. R. Denburg, A. M. Manibo, R. A. Lobo, R. Jaffe, M. Ferin, L. S. Levine, and S. E. Oberfield
Early Endocrine, Metabolic, and Sonographic Characteristics of Polycystic Ovary Syndrome (PCOS): Comparison between Nonobese and Obese Adolescents
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4682 - 4688.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
G. M. Kalish, E. Barrett-Connor, G. A. Laughlin, and B. I. Gulanski
Association of Endogenous Sex Hormones and Insulin Resistance among Postmenopausal Women: Results from the Postmenopausal Estrogen/Progestin Intervention Trial
J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1646 - 1652.
[Abstract] [Full Text] [PDF]

Home page
 Obstet GynecolHome page
R. L. Barbieri
Metformin for the Treatment of Polycystic Ovary Syndrome
Obstet. Gynecol., April 1, 2003; 101(4): 785 - 793.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. J. Moran, M. Noakes, P. M. Clifton, L. Tomlinson, and R. J. Norman
Dietary Composition in Restoring Reproductive and Metabolic Physiology in Overweight Women with Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., February 1, 2003; 88(2): 812 - 819.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
S. S. George, K. George, C. Irwin, V. Job, R. Selvakumar, V. Jeyaseelan, and M.S. Seshadri
Sequential treatment of metformin and clomiphene citrate in clomiphene-resistant women with polycystic ovary syndrome: a randomized, controlled trial
Hum. Reprod., February 1, 2003; 18(2): 299 - 304.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Epidemiol. Biomarkers Prev.Home page
R. Kaaks, A. Lukanova, and M. S. Kurzer
Obesity, Endogenous Hormones, and Endometrial Cancer Risk: A Synthetic Review
Cancer Epidemiol. Biomarkers Prev., December 1, 2002; 11(12): 1531 - 1543.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. R. Denburg, M. E. Silfen, A. M. Manibo, D. Chin, L. S. Levine, M. Ferin, D. J. McMahon, C. Go, and S. E. Oberfield
Insulin Sensitivity and the Insulin-Like Growth Factor System in Prepubertal Boys with Premature Adrenarche
J. Clin. Endocrinol. Metab., December 1, 2002; 87(12): 5604 - 5609.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Silfen, C. H. L. Shackleton, A. M. Manibo, L. S. Levine, D. Sekhar, D. J. McMahon, and S. E. Oberfield
5{alpha}-Reductase and 11{beta}-Hydroxysteroid Dehydrogenase Activity in Prepubertal Hispanic Girls with Premature Adrenarche
J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4647 - 4651.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
V. Jayagopal, E. S. Kilpatrick, S. Holding, P. E. Jennings, and S. L. Atkin
The Biological Variation of Insulin Resistance in Polycystic Ovarian Syndrome
J. Clin. Endocrinol. Metab., April 1, 2002; 87(4): 1560 - 1562.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
H. Yarali, B. O. Yildiz, A. Demirol, H. B. Zeyneloglu, N. Yigit, O. Bukulmez, and Z. Koray
Co-administration of metformin during rFSH treatment in patients with clomiphene citrate-resistant polycystic ovarian syndrome: a prospective randomized trial
Hum. Reprod., February 1, 2002; 17(2): 289 - 294.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. E. Silfen, A. M. Manibo, M. Ferin, D. J. McMahon, L. S. Levine, and S. E. Oberfield
Elevated Free IGF-I Levels in Prepubertal Hispanic Girls with Premature Adrenarche: Relationship with Hyperandrogenism and Insulin Sensitivity
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 398 - 403.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, A. E. Calogero, M. Farina, V. De Leo, A. La Marca, and A. Cianci
Clinical, endocrine and metabolic effects of acarbose, an {alpha}-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance
Hum. Reprod., October 1, 2001; 16(10): 2066 - 2072.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
R. Azziz, D. Ehrmann, R. S. Legro, R. W. Whitcomb, R. Hanley, A. G. Fereshetian, M. O’Keefe, and M. N. Ghazzi
Troglitazone Improves Ovulation and Hirsutism in the Polycystic Ovary Syndrome: A Multicenter, Double Blind, Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1626 - 1632.
[Abstract] [Full Text]

Home page
 Endocr. Rev.Home page
L. Ibáñez, J. DiMartino-Nardi, N. Potau, and P. Saenger
Premature Adrenarche--Normal Variant or Forerunner of Adult Disease?
Endocr. Rev., December 1, 2000; 21(6): 671 - 696.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
V. De Leo, A. la Marca, G. Morgante, L. Ciotta, L. Mencaglia, A. Cianci, and F. Petraglia
Clomiphene citrate increases insulin-like growth factor binding protein-1 and reduces insulin-like growth factor-I without correcting insulin resistance associated with polycystic ovarian syndrome
Hum. Reprod., November 1, 2000; 15(11): 2302 - 2305.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Ibáñez, C. Valls, N. Potau, M. V. Marcos, and F. de Zegher
Sensitization to Insulin in Adolescent Girls to Normalize Hirsutism, Hyperandrogenism, Oligomenorrhea, Dyslipidemia, and Hyperinsulinism after Precocious Pubarche
J. Clin. Endocrinol. Metab., October 1, 2000; 85(10): 3526 - 3530.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. K. Wickenheisser, P. G. Quinn, V. L. Nelson, R. S. Legro, J. F. Strauss III, and J. M. McAllister.
Differential Activity of the Cytochrome P450 17{alpha}-Hydroxylase and Steroidogenic Acute Regulatory Protein Gene Promoters in Normal and Polycystic Ovary Syndrome Theca Cells
J. Clin. Endocrinol. Metab., June 1, 2000; 85(6): 2304 - 2311.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. L. Chang, S. R. Lindheim, C. Lowre, M. Ferin, F. Gonzalez, L. Berglund, E. Carmina, M. V. Sauer, and R. A. Lobo
Normal Ovulatory Women with Polycystic Ovaries Have Hyperandrogenic Pituitary-Ovarian Responses To Gonadotropin-Releasing Hormone-Agonist Testing
J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 995 - 1000.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Moghetti, R. Castello, C. Negri, F. Tosi, F. Perrone, M. Caputo, E. Zanolin, and M. Muggeo
Metformin Effects on Clinical Features, Endocrine and Metabolic Profiles, and Insulin Sensitivity in Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled 6-Month Trial, followed by Open, Long-Term Clinical Evaluation
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 139 - 146.
[Abstract] [Full Text]

Home page
 Hum ReprodHome page
R.D. Murray, R.M. Davison, R.C. Russell, and G.S. Conway
Clinical presentation of PCOS following development of an insulinoma: Case Report
Hum. Reprod., January 1, 2000; 15(1): 86 - 88.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
L. Ciotta, V. De Leo, F. Galvani, A. La Marca, and A. Cianci
Endocrine and metabolic effects of octreotide, a somatostatin analogue, in lean PCOS patients with either hyperinsulinaemia or lean normoinsulinaemia
Hum. Reprod., December 1, 1999; 14(12): 2951 - 2958.
[Abstract] [Full Text] [PDF]

Home page
 Hum ReprodHome page
I.R. Pirwany, R.W.S. Yates, I.T. Cameron, and R. Fleming
Effects of the insulin sensitizing drug metformin on ovarian function, follicular growth and ovulation rate in obese women with oligomenorrhoea
Hum. Reprod., December 1, 1999; 14(12): 2963 - 2968.
[Abstract] [Full Text] [PDF]

Home page
 Biol. Reprod.Home page
R. Z. Spaczynski, A. Arici, and A. J. Duleba
Tumor Necrosis Factor-{alpha} Stimulates Proliferation of Rat Ovarian Theca-Interstitial Cells
Biol Reprod, October 1, 1999; 61(4): 993 - 998.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C.-B. Book and A. Dunaif
Selective Insulin Resistance in the Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3110 - 3116.
[Abstract] [Full Text]

Home page
 Postgrad. Med. J.Home page
S L E Pfeifer, R M Wilson, and D J Gawkrodger
Clearance of acanthosis nigricans associated with the HAIR-AN syndrome after partial pancreatectomy: an 11-year follow-up
Postgrad. Med. J., July 1, 1999; 75(885): 421 - 423.
[Abstract] [Full Text]

Home page
 Mol. Endocrinol.Home page
J. F. Strauss III and A. Dunaif
Molecular Mysteries of Polycystic Ovary Syndrome
Mol. Endocrinol., June 1, 1999; 13(6): 800 - 805.
[Full Text]

Home page
 Mol. Endocrinol.Home page
V. L. Nelson, R. S. Legro, J. F. Strauss III, and J. M. McAllister
Augmented Androgen Production Is a Stable Steroidogenic Phenotype of Propagated Theca Cells from Polycystic Ovaries
Mol. Endocrinol., June 1, 1999; 13(6): 946 - 957.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
P. Vuguin, B. Linder, R. G. Rosenfeld, P. Saenger, and J. DiMartino-Nardi
The Roles of Insulin Sensitivity, Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Protein-1 and -3 in the Hyperandrogenism of African-American and Caribbean Hispanic Girls with Premature Adrenarche
J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2037 - 2042.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Nagamani, C. Osuampke, and M. E. Kelver
Increased Bioactive Luteinizing Hormone Levels and Bio/Immuno Ratio in Women with Hyperthecosis of the Ovaries: Possible Role of Hyperinsulinemia
J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1685 - 1689.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. P. Diamond, D. Grainger, M. C. Diamond, R. S. Sherwin, and R. A. DeFronzo
Effects of Methyltestosterone on Insulin Secretion and Sensitivity In Women
J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4420 - 4425.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T. M. Fiad, T. P. Smith, S. K. Cunningham, and T. J. McKenna
Decline in Insulin-Like Growth Factor I Levels after Clomiphene Citrate Does Not Correct Hyperandrogenemia in Polycystic Ovary Syndrome
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2394 - 2398.
[Abstract] [Full Text]

Home page
 NEJMHome page
J. E. Nestler, D. J. Jakubowicz, W. S. Evans, and R. Pasquali
Effects of Metformin on Spontaneous and Clomiphene-Induced Ovulation in the Polycystic Ovary Syndrome
N. Engl. J. Med., June 25, 1998; 338(26): 1876 - 1880.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. E. Nestler, D. J. Jakubowicz, A. Falcon de Vargas, C. Brik, N. Quintero, and F. Medina
Insulin Stimulates Testosterone Biosynthesis by Human Thecal Cells from Women with Polycystic Ovary Syndrome by Activating Its Own Receptor and Using Inositolglycan Mediators as the Signal Transduction System
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 2001 - 2005.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Laivuori, R. Kaaja, E.-M. Rutanen, L. Viinikka, and O. Ylikorkala
Evidence of High Circulating Testosterone in Women with Prior Preeclampsia
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 344 - 347.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
C. L. Pastor, M. L. Griffin-Korf, J. A. Aloi, W. S. Evans, and J. C. Marshall
Polycystic Ovary Syndrome: Evidence for Reduced Sensitivity of the Gonadotropin-Releasing Hormone Pulse Generator to Inhibition by Estradiol and Progesterone
J. Clin. Endocrinol. Metab., February 1, 1998; 83(2): 582 - 590.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
J. E. Nestler and D. J. Jakubowicz
Lean Women with Polycystic Ovary Syndrome Respond to Insulin Reduction with Decreases in Ovarian P450c17{alpha} Activity and Serum Androgens
J. Clin. Endocrinol. Metab., December 1, 1997; 82(12): 4075 - 4079.
[Abstract] [F